Euro
USD
British Pound
NULL
Product Description
The SARS-CoV-2 spike protein (S glycoprotein) is found on the outside of the virus particle and gives the coronavirus its crown-like appearance. The S glycoprotein mediates attachment of the virus particle to cell surface receptors such as ACE2, which facilitates viral entry into the host cell. S glycoprotein is an important target for vaccine development, antibody therapies, and diagnostic testing. The original monoclonal antibody against the S glycoprotein is currently being investigated in clinical trials of COVID-19 treatment.
Biovision | A2292 | Anti-SARS-CoV-2 RBD (Bamlanivimab), Humanized Antibody DataSheet
Antibody Target: SARS-CoV-2 receptor binding domain (RBD) / spike protein
Target Alternative Name: Spike glycoprotein; S glycoprotein; Spike protein S1; Spike protein S2; Spike protein S2'; receptor binding domain [SARS-CoV-2]; RBD [SARS-CoV-2]
Tag Line: A humanized monoclonal antibody that binds to and inhibits the binding of the SARS-CoV-2 spike protein to cell surface receptors
Category: GM-CSF
Host:
Isotype: IgG
Species Reactivities: FALSE
Immunogen Sequence: FALSE
Accession #: P0DTC2
Gene ID: 43740568
Appearance: Liquid
Form:
Concentration: 1 mg/mL
Formulation: In PBS, pH 7.5
Purification: FALSE
Application: FALSE
Positive Control:
Application And Usages:
Country of Animal Origin: USA
Country of Manufacture: USA
Usage: For Research Use Only! Not to be used in humans.
Handling: The antibody solution should be gently mixed before use.
Western Blot Verified: FALSE
Immunocytochemistry Verified:
Immunofluorescence Verified: FALSE
Immunoprecipitation Verified: FALSE
FACS Verified:
ELISA Verified: FALSE
ChIP Verified: FALSE
Dot Blot Verified: FALSE
Flow Cytometry Verified: FALSE
